Network meta-analysis of topical haemostatic agents in thyroid surgery
- PMID: 30199093
- DOI: 10.1002/bjs.10975
Network meta-analysis of topical haemostatic agents in thyroid surgery
Abstract
Background: The objective of this study was to investigate the potential benefit of local haemostatic agents for the prevention of postoperative bleeding after thyroidectomy.
Methods: A systematic literature search was performed, and RCTs involving adult patients who underwent thyroid surgery using either active (AHA) or passive (PHA) haemostatic agents were included in the review. The main outcome was the rate of cervical haematoma that required reoperation. A Bayesian random-effects model was used for network meta-analysis with minimally informative prior distributions.
Results: Thirteen RCTs were included. The rate of cervical haematoma requiring reoperation ranged from 0 to 9·1 per cent, and was not reduced by haemostatic agents: AHA versus control (odds ratio (OR) 1·53, 95 per cent credibility interval 0·21 to 10·77); PHA versus control (OR 2·74, 0·41 to 16·62) and AHA versus PHA (OR 1·77, 0·12 to 25·06). No difference was observed in the time required for drain removal, duration of hospital stay, and the rate of postoperative hypocalcaemia or recurrent nerve palsy. AHA led to a significantly lower total postoperative blood loss and reduced operating time in comparison with both the control and PHA groups.
Conclusion: The general use of local haemostatic agents has not been shown to reduce the rate of clinically relevant bleeding.
© 2018 BJS Society Ltd Published by John Wiley & Sons Ltd.
Similar articles
-
The use of a biologic topical haemostatic agent (TachoSil(®)) for the prevention of postoperative bleeding in patients on antithrombotic therapy undergoing thyroid surgery: A randomised controlled pilot trial.Int J Surg. 2015 Aug;20:95-100. doi: 10.1016/j.ijsu.2015.06.027. Epub 2015 Jun 14. Int J Surg. 2015. PMID: 26079499 Clinical Trial.
-
The use of haemostatic agents in thyroid surgery: efficacy and further advantages. Collagen-Fibrinogen-Thrombin Patch (CFTP) versus Cellulose Gauze.Ann Ital Chir. 2013 Sep-Oct;84(5):545-50. Ann Ital Chir. 2013. PMID: 23502460 Clinical Trial.
-
Does a thrombin-based topical haemostatic agent reduce blood loss and transfusion requirements after total knee revision surgery? A randomized, controlled trial.Knee Surg Sports Traumatol Arthrosc. 2015 Nov;23(11):3337-42. doi: 10.1007/s00167-014-3153-8. Epub 2014 Jul 11. Knee Surg Sports Traumatol Arthrosc. 2015. PMID: 25011643 Clinical Trial.
-
Fibrin-based haemostatic agents for reducing blood loss in adult liver resection.Cochrane Database Syst Rev. 2023 Aug 8;8(8):CD010872. doi: 10.1002/14651858.CD010872.pub2. Cochrane Database Syst Rev. 2023. PMID: 37551841 Free PMC article. Review.
-
Tranexamic acid for patients with nasal haemorrhage (epistaxis).Cochrane Database Syst Rev. 2018 Dec 31;12(12):CD004328. doi: 10.1002/14651858.CD004328.pub3. Cochrane Database Syst Rev. 2018. PMID: 30596479 Free PMC article.
Cited by
-
The effectiveness of fibrin sealants in head and neck surgery: a systematic review and meta-analysis.Syst Rev. 2024 Sep 28;13(1):246. doi: 10.1186/s13643-024-02634-w. Syst Rev. 2024. PMID: 39342380 Free PMC article.
-
Editorial: Recent Advances in Thyroid Surgery.J Clin Med. 2022 Dec 6;11(23):7233. doi: 10.3390/jcm11237233. J Clin Med. 2022. PMID: 36498807 Free PMC article.
-
Effectiveness of Hemopatch® versus Surgicel® Original to control mild and moderate liver bleeding.BMC Surg. 2022 Aug 14;22(1):316. doi: 10.1186/s12893-022-01747-0. BMC Surg. 2022. PMID: 35965336 Free PMC article.
-
Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES-AAST consensus paper.World J Emerg Surg. 2024 Jul 16;19(1):26. doi: 10.1186/s13017-024-00554-7. World J Emerg Surg. 2024. PMID: 39010099 Free PMC article. Review.
-
Use of technologies in thyroid surgery: Latin American Thyroid Society Surgical Affairs Committee Expert Opinion. Part 1.Arch Endocrinol Metab. 2025 Apr 3;69(2):e240111. doi: 10.20945/2359-4292-2024-0111. Arch Endocrinol Metab. 2025. PMID: 40179268 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources